Analyst Ratings for Turning Point Therapeutics Inc. (TPTX)

TPTX Rating Summary

  |   Expand Research on TPTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.6 / 10   Percentile Rank: 34%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/13/2022 Guggenheim Michael Schmidt Downgrade Neutral
(Buy)		 76.00
(N/A)		 74.47
(76.01)		 2.07% Details
6/13/2022 Leerink Partners Andrew S. Berens Downgrade Market Perform
(Outperform)		 76.00
(101.00)		 74.47
(76.01)		 2.07% Details